US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Decoy Therapeutics Inc

0.7799

+0.159925.79%

Post-market: 0.7177-0.0622-7.97%19:48 EST

Volume:617.77K

Turnover:458.52K

Market Cap:4.98M

PE:-0.02

High:0.7824

Open:0.6394

Low:0.6300

Close:0.6200

52wk High:34.65

52wk Low:0.5148

Shares:6.38M

Float Shares:6.34M

Volume Ratio:2.75

T/O Rate:9.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-39.1909

EPS(LYR):-86.9214

ROE:-139.55%

ROA:-69.91%

PB:1.17

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Decoy Therapeutics Showcases Antiviral Platform at Webull Financial Corporate Connect Webinar

Decoy Therapeutics gibt Global Access Commitment Agreement mit Gates Foundation bekannt

Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement

THOMSON REUTERS

Decoy Therapeutics initiated with a Buy at Ladenburg

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/DCOY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DCOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","market":"US","secType":"STK","nameCN":"Decoy Therapeutics Inc","latestPrice":0.7799,"timestamp":1770411600000,"preClose":0.62,"halted":0,"volume":617768,"hourTrading":{"tag":"盘后","latestPrice":0.717735,"preClose":0.7799,"latestTime":"19:48 EST","volume":12916,"amount":9405.5168,"timestamp":1770425310779,"change":-0.062165,"changeRate":-0.079709,"amplitude":0.087832},"delay":0,"changeRate":0.2579032258064517,"floatShares":6341106,"shares":6384200,"eps":-39.1909,"marketStatus":"Market Closed","change":0.1599,"latestTime":"02-06 16:00:00 EST","open":0.6394,"high":0.7824,"low":0.63,"amount":458521.08080584,"amplitude":0.245806,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-39.1909,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":0.62,"preHourTrading":{"tag":"盘前","latestPrice":0.6399,"preClose":0.62,"latestTime":"08:33 EST","volume":219,"amount":143.5449078,"timestamp":1770384806848,"change":0.0199,"changeRate":0.032097,"amplitude":0.24371},"postHourTrading":{"tag":"盘后","latestPrice":0.717735,"preClose":0.7799,"latestTime":"19:48 EST","volume":12916,"amount":9405.5168,"timestamp":1770425310779,"change":-0.062165,"changeRate":-0.079709,"amplitude":0.087832},"volumeRatio":2.751032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","floatShares":6341106,"roa":"-69.91%","roe":"-139.55%","lyrEps":-86.921415,"volumeRatio":2.751032,"shares":6384200,"dividePrice":0,"high":0.7824,"amplitude":0.245806,"preClose":0.62,"low":0.63,"week52Low":0.5148,"pbRate":"1.17","week52High":34.65,"institutionHeld":0,"latestPrice":0.7799,"eps":-39.1909,"divideRate":0,"volume":617768,"delay":0,"ttmEps":-39.1909,"open":0.6394,"prevYearClose":0.6488,"prevWeekClose":0.7709,"prevMonthClose":0.7709,"prevQuarterClose":0.6488},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DCOY\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DCOY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DCOY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DCOY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DCOY","date":"2026-02-05","current":-0.0199,"percent":1,"low":-1.594527,"twenty":-1.103464,"median":-1.039823,"eighty":-0.949547,"high":-0.803641,"avg":-1.0474,"sd":0.157895,"marketCap":4022031},"quantilePoints":[{"date":"2026-01-09","current":-0.982229,"twenty":-1.053663,"median":-1.026876,"eighty":-1.000088,"marketCap":4915816},{"date":"2026-01-16","current":-1.227403,"twenty":-1.203881,"median":-1.071522,"eighty":-1.040856,"marketCap":6142855},{"date":"2026-01-23","current":-0.957354,"twenty":-1.160688,"median":-1.045754,"eighty":-0.982229,"marketCap":4791324},{"date":"2026-01-30","current":-1.05749,"twenty":-1.109791,"median":-1.050666,"eighty":-0.994985,"marketCap":5292482},{"date":"2026-02-05","current":-0.803641,"twenty":-1.103464,"median":-1.039823,"eighty":-0.949547,"marketCap":4022031}],"updateTime":1770440937476},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DCOY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609306791","title":"Decoy Therapeutics Showcases Antiviral Platform at Webull Financial Corporate Connect Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2609306791","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609306791?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:15","pubTimestamp":1770300929,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Inc. will participate in the Corporate Connect Webinar Series hosted by Webull Financial, taking place virtually on February 10-11, 2026. The company's Chief Executive Officer, Rick Pierce, is scheduled to give a corporate overview and discuss their new class of antiviral therapeutics on Tuesday, February 10, 2026, at 1:20 PM EST.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Decoy Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL1HLB7d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BK4139","DCOY"],"gpt_icon":0},{"id":"2608336724","title":"Decoy Therapeutics gibt Global Access Commitment Agreement mit Gates Foundation bekannt","url":"https://stock-news.laohu8.com/highlight/detail?id=2608336724","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608336724?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:02","pubTimestamp":1770213738,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Decoy Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDLXHJPq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"gpt_icon":0},{"id":"2608417367","title":"Decoy Therapeutics Participates in Virtual Investor \"What This Means\" Segment Highlighting Recently Announced Global Access Commitment Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608417367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608417367?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:02","pubTimestamp":1770213720,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA94F65Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DCOY"],"gpt_icon":0},{"id":"2605474750","title":"Decoy Therapeutics initiated with a Buy at Ladenburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2605474750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605474750?lang=en_us&edition=fundamental","pubTime":"2026-01-23 19:40","pubTimestamp":1769168421,"startTime":"0","endTime":"0","summary":"Ladenburg initiated coverage of Decoy Therapeutics (DCOY) with a Buy rating and $2.50 price target Published first on TheFly – the ultimate source ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-initiated-with-a-buy-at-ladenburg-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-initiated-with-a-buy-at-ladenburg-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","DCOY","LENZ","BK4007","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DCOY\",params:#limit:6,delay:false,,,undefined,":[]}}